Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Human umbilical cord blood monocytes, but not adult blood monocytes, rescue brain cells from hypoxic-ischemic injury: Mechanistic and therapeutic implications.

Saha A, Patel S, Xu L, Scotland P, Schwartzman J, Filiano AJ, Kurtzberg J, Balber AE.

PLoS One. 2019 Sep 4;14(9):e0218906. doi: 10.1371/journal.pone.0218906. eCollection 2019.

2.

Cord Blood Connect: The International Congress for Cord Blood and Perinatal Tissue Research.

Saha A, Patel S, Xu L, Filiano AJ, Balber AE, Kurtzberg J.

Stem Cells Transl Med. 2019 Sep;8 Suppl 1:S1-S35. doi: 10.1002/sctm.12550. No abstract available.

3.

Gene products promoting remyelination are up-regulated in a cell therapy product manufactured from banked human cord blood.

Scotland P, Buntz S, Noeldner P, Saha A, Gentry T, Kurtzberg J, Balber AE.

Cytotherapy. 2017 Jun;19(6):771-782. doi: 10.1016/j.jcyt.2017.03.004. Epub 2017 Apr 5.

PMID:
28391986
4.

A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Saha A, Buntz S, Scotland P, Xu L, Noeldner P, Patel S, Wollish A, Gunaratne A, Gentry T, Troy J, Matsushima GK, Kurtzberg J, Balber AE.

JCI Insight. 2016 Aug 18;1(13):e86667. doi: 10.1172/jci.insight.86667.

5.

Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay.

Shoulars K, Noldner P, Troy JD, Cheatham L, Parrish A, Page K, Gentry T, Balber AE, Kurtzberg J.

Blood. 2016 May 12;127(19):2346-54. doi: 10.1182/blood-2015-08-666990. Epub 2016 Mar 11.

6.

Reprint of: Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.

Kurtzberg J, Buntz S, Gentry T, Noeldner P, Ozamiz A, Rusche B, Storms RW, Wollish A, Wenger DA, Balber AE.

Cytotherapy. 2015 Sep;17(9):1314-26. doi: 10.1016/j.jcyt.2015.07.014.

PMID:
26276011
7.

Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.

Kurtzberg J, Buntz S, Gentry T, Noeldner P, Ozamiz A, Rusche B, Storms RW, Wollish A, Wenger DA, Balber AE.

Cytotherapy. 2015 Jun;17(6):803-815. doi: 10.1016/j.jcyt.2015.02.006. Epub 2015 Mar 12.

8.

Development of a flow cytometry-based pulse-width assay for detection of aggregates in cellular therapeutics to be infused by catheter.

Hickerson DHM, White HS, Nguyen A, Nieman E, Meadows N, Gentry T, Foster SJ, Balber AE, Fiordalisi M, Hinson JM Jr.

Cytotherapy. 2014 Nov;16(11):1545-1557. doi: 10.1016/j.jcyt.2014.05.004. Epub 2014 Jun 24.

PMID:
24972743
9.

Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.

Page KM, Mendizabal A, Betz-Stablein B, Wease S, Shoulars K, Gentry T, Prasad VK, Sun J, Carter S, Balber AE, Kurtzberg J.

Transfusion. 2014 Feb;54(2):340-52. doi: 10.1111/trf.12257. Epub 2013 May 27.

10.

The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME).

Page KM, Zhang L, Mendizabal A, Wease S, Carter S, Shoulars K, Gentry T, Balber AE, Kurtzberg J.

Transfusion. 2012 Feb;52(2):272-83. doi: 10.1111/j.1537-2995.2011.03278.x. Epub 2011 Aug 2.

12.

Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.

Page KM, Zhang L, Mendizabal A, Wease S, Carter S, Gentry T, Balber AE, Kurtzberg J.

Biol Blood Marrow Transplant. 2011 Sep;17(9):1362-74. doi: 10.1016/j.bbmt.2011.01.011. Epub 2011 Jan 28.

13.

Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood.

Gentry T, Deibert E, Foster SJ, Haley R, Kurtzberg J, Balber AE.

Cytotherapy. 2007;9(6):569-76.

PMID:
17882722
14.

Modification of a commercial cell sorter to support efficient and reliable preparation of ALDH-bright cells for clinical use.

Hickerson D, Fiordalisi M, Reese M, Deibert E, Balber AE, Kurtzberg J, Haley NR.

Cytotherapy. 2007;9(6):562-8.

PMID:
17882721
15.
16.
17.

Developmentally regulated trafficking of the lysosomal membrane protein p67 in Trypanosoma brucei.

Alexander DL, Schwartz KJ, Balber AE, Bangs JD.

J Cell Sci. 2002 Aug 15;115(Pt 16):3253-63.

18.

Molecular cloning of p67, a lysosomal membrane glycoprotein from Trypanosoma brucei.

Kelley RJ, Alexander DL, Cowan C, Balber AE, Bangs JD.

Mol Biochem Parasitol. 1999 Jan 5;98(1):17-28.

PMID:
10029306
19.

Processing and transport of a lysosomal membrane glycoprotein is developmentally regulated in African trypanosomes.

Kelley RJ, Brickman MJ, Balber AE.

Mol Biochem Parasitol. 1995 Nov;74(2):167-78.

PMID:
8719158
20.
22.
23.

Trypanosoma brucei rhodesiense: the inhibition of HL-60 cell growth by the African trypanosomes in vitro.

Keku TO, Seed JR, Sechelski JB, Balber A.

Exp Parasitol. 1993 Nov;77(3):306-14.

PMID:
8224086
24.

Molecular cloning and cellular localization of a BiP homologue in Trypanosoma brucei. Divergent ER retention signals in a lower eukaryote.

Bangs JD, Uyetake L, Brickman MJ, Balber AE, Boothroyd JC.

J Cell Sci. 1993 Aug;105 ( Pt 4):1101-13.

25.
26.
30.
32.

Trypanosoma brucei gambiense: partitioning of glycopeptides of bloodstream and procyclic forms in Triton X-114.

Balber AE, Ho LM.

Exp Parasitol. 1988 Apr;65(2):290-3. No abstract available.

PMID:
3350109
33.
35.

Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.

Sturtevant JE, Balber AE.

Exp Parasitol. 1987 Jun;63(3):260-71.

PMID:
3556206
37.
38.
39.
40.
42.

Inosine analogs as chemotherapeutic agents for African trypanosomes: metabolism in trypanosomes and efficacy in tissue culture.

Fish WR, Marr JJ, Berens RL, Looker DL, Nelson DJ, LaFon SW, Balber AE.

Antimicrob Agents Chemother. 1985 Jan;27(1):33-6.

43.

H-2 antigens of certain t and non-t mice react with the same monoclonal antibody.

Balber AE, Amos DB, Artzt K.

J Immunogenet. 1984 Apr;11(2):127-33.

PMID:
6202798
44.
46.
47.

Immunosuppression by human alpha 2-macroglobulin, a 3800 Mr peptide, and other derivatives.

Hubbard WJ, Anderson BD, Balber AE, Praud GM, Alomran AM, Shenton BK.

Ann N Y Acad Sci. 1983;421:332-9. No abstract available.

PMID:
6202201
48.
49.
50.

Protein uptake and digestion in bloodstream and culture forms of Trypanosoma brucei.

Langreth SG, Balber AE.

J Protozool. 1975 Feb;22(1):40-53.

PMID:
1117436

Supplemental Content

Loading ...
Support Center